InvestorsHub Logo
Followers 2
Posts 333
Boards Moderated 0
Alias Born 07/11/2018

Re: None

Friday, 03/01/2019 10:21:04 AM

Friday, March 01, 2019 10:21:04 AM

Post# of 15300
Raymond James posted a buy and PT $73.00. On the call the RJ analyst questioned Art on 2019 guidance at 238M (mid point). As he and I had thought ANI was low balling that number based on pipeline releases and 2H 2018 revenue. Thinking just about Methylphenidate ER that will be released this month, the total market is 1.3B. Per Art they have 7-8 competitors for this drug. Assume only 6 months of just 5% market share that would be ~32.5M in 2019 on this drug alone. Art said they are being very conservative on guidance. I think they are as well!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News